Low Dose Naltrexone
Naltrexone is within a class of drugs called opioid antagonist, which basically means the drug blocks the action of opiate drugs, such as hydrocodone, in our body. Historically, at high doses, the drug has been used to treat narcotic addictions.
It has been discovered at a low dose, Naltrexone (LDN) can help reduce inflammation and reduce autoimmune activity. It may also help boost the immune system.
Potential patient benefits:
Studies have shown LDN is effective in improving the function of the immune system. This immune system efficiency may help your body:
- Recover from sickness
- Strengthen and balance your immune system
- Enhance sleep
- Lessen symptoms and help body repair from autoimmune diseases
- Relieve symptoms and help body repair from chronic medical disorders
- Regulate cell growth
- Build immunity
- Reduce allergies
- Relieve depression
- Reduce alcohol, sugar and food cravings
What kind of disease has LDN reportedly helped?
Studies have shown that LDN has helped patients with:
- Fibromyalgia
- Chronic Fatigue Syndrome
- Lupus
- Cancer
- Autoimmune
- Multiple Sclerosis
- Depression
- Sarcoidosis
- Arthritis
- Psoriasis
- Lyme Disease
- Diabetic Neuropathy
- Chronic Pain
- Bipolar disorder
- PTSD
- Depression
- Irritable Bowel Syndrome (Crohn’s Disease, Colitis)
- HIV
What is Low Dose Naltrexone (LDN)?
LDN has been used to counter alcohol abuse and food cravings in addicted persons. Healthcare providers have expanded its use to successfully treat patients with autoimmune diseases such as Hashimoto’s thyroiditis, Crohn’s disease and a host of others. Many alternative cancer practitioners include LDN as a part of a treatment regimen.
When taken at night, LDN attaches to opioid receptors, blocking endorphins from attaching to them. This causes the body to release additional endorphins. A surge in endorphins causes increased activity from stem cells and immune cells, making your immune system work more efficiently. LDN keeps the immune system from overworking, however, which is a problem in autoimmune diseases.
